Recently added articles from MondayMorning:
Celgene buying Gloucester Pharma for $640 million.(CORPORATE)(Brief article)
Dec 14, 2009 ... Celgene Buying Gloucester Pharma for $640 Million. Biotechnology company Celgene Corp. (Summit NJ) said it will buy privately held Gloucester Pharmaceuticals Inc. (Cambridge MA) for $640 million, thereby obtaining access to key cancer drugs. The deal includes $340 million in cash upfront ...
Tracking Washington.(TOP STORIES)(Brief article)
Dec 14, 2009 ... Tracking Washington: Senate Republicans accused Democrats of pandering to the pharmaceutical industry and putting off a vote on a bipartisan plan that would have allowed the importation of cheaper prescription drugs from Canada. Arizona Senator John McCain, a Republican co-sponsor of the ...
Allos Therapeutics Inc.(Medical Stock Spotlight)(Brief article)
Dec 14, 2009 ... And Allos Therapeutics Inc. (Nasdaq) tumbled 76 cents, or 11%, to $5.86 following news of a deal that could boost sales of a rival cancer drug that competes with Allos' Folotyn. The latter is an injectable treatment for peripheral T-cell lymphoma, a rare and aggressive type of lymphatic ...
Somaxon Pharmaceuticals Inc.(Medical Stock Spotlight)(drug approval)(Brief article)
Dec 14, 2009 ... But Somaxon Pharmaceuticals Inc. (Nasdaq) plunged $2.38, or 67%--the most in nine months--after the company said its insomnia pill was rejected for the second time this year by the FDA. The San Diego-based company said the FDA questioned the effectiveness of the drug, Silenor, and declared ...
Senators move to block drugmakers from mining Rx data.(TOP STORIES)(Brief article)
Dec 14, 2009 ... Senators Move to Block Drugmakers from Mining Rx Data. Drug companies would no longer be able to mine pharmacy records to track which doctors are prescribing their medications, under a proposal unveiled Thursday by two Senate Democrats. The amendment to the Senate healthcare bill would ...